SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
NAT yield in blood donors: An observational study
14 references·0 citing·39 second hop
NAT yield in blood donors: An observational study (2023)NAT yield in blood donors: An observation…Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India (2019)Initial trends of individual …Efficacy of Nucleic Acid Amplification Test (NAT) over Enzyme Linked Immuno Sorbent Assay (ELISA) in Detecting Transfusion Transmissible Infections (TTI) among Blood Donors at a Tertiary Care Centre (2019)Efficacy of Nucleic Acid Ampl…Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations (2017)Sensitivity and specificity o…Nucleic acid amplification testing in Indian blood banks: A review with perspectives (2017)Nucleic acid amplification te…A study of centralized individual donor nucleic acid testing for transfusion transmitted infections to improve blood safety in Karnataka, India (2017)A study of centralized indivi…Significance of nucleic acid testing in window period donations: Revisiting transfusion safety in high prevalence-low resource settings (2016)Significance of nucleic acid …Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India (2015)Seroprevalence of infectious …Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety (2015)Individual donor-nucleic acid…Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety (2015)Automated nucleic acid amplif…Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India (2013)Nucleic acid testing for bloo…Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital. (2013)Individual donor nucleic acid…Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors (2013)Evaluation of serological tra…Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections (2012)Need for Nucleic Acid Testing…Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms (2010)Refinement of a viral transmi…Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population (2002)Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing (2004)A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors (2005)Screening Donated Blood for Transfusion Transmitted Infections by Serology along with NAT and Response Rate to Notification of Reactive Results: An Indian Experience (2014)NAT of the United States and Canadian blood supply (2000)Nucleic acid amplification testing of blood donors fortransfusion‐transmitted infectious diseases (2000)Residual risk of transmission of human immunodeficiency virus and hepatitis C virus infections by blood transfusion in northern Brazil (2017)Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia (2017)Assessment of Blood Donation and Transfusion in Eastern Uganda: A Mixed-Methods Study (2019)High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type-1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan (2003)Cost‐effectiveness of nucleic acid test screening of volunteer blood donations for hepatitis B, hepatitis C and human immunodeficiency virus in the United States (2004)International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 (2011)Seroprevalence & changing trends of transfusion-transmitted infections amongst blood donors in a Regional Blood Transfusion Centre in north India (2017)The Risk of Transfusion-Transmitted Viral Infections (1996)Automated Triplex (HBV, HCV and HIV) NAT Assay Systems for Blood Screening in India (2016)Quality and safety measures in transfusion practice: The experience of eight southern/eastern Mediterranean countries (2020)The Prevalence of Transfusion-transmitted Infections among Blood Donors in Hospital Universiti Sains Malaysia (2020)Impact of individual‐donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa (2009)Infectivity of human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion (2009)Assessment of HIV transfusion transmission risk in South Africa: a 10‐year analysis following implementation of individual donation nucleic acid amplification technology testing and donor demographics eligibility changes (2018)Screening Blood Donors for HIV, HCV, and HBV at the American Red Cross: 10-Year Trends in Prevalence, Incidence, and Residual Risk, 2007 to 2016 (2020)HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men (2021)Prevalence and Trends of Markers of Hepatitis C Virus, Hepatitis B Virus and Human Immunodeficiency Virus in Delhi Blood Donors: A Hospital Based Study (2007)Transfusion-transmitted infections (2007)Seroprevalence of HIV, HBV, HCV and syphilis in blood donors in Southern Haryana (2010)The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia (2018)Seroprevalence and associated risk factors for HIV, Hepatitis B and C among blood Donors in South Gondar District blood Bank, Northwest Ethiopia (2019)Prevalence of Transfusion-Transmitted Infections (HCV, HIV, Syphilis and Malaria) in Blood Donors: A Large-Scale Cross-Sectional Study (2022)Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing (2005)Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT) (2005)Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6‐year survey (2008)Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting (2022)A comparative analysis between NAT and chemiluminescence in detection of transfusion transmitted viruses in two main university blood transfusion centers (2025)Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing (2010)Efficacy of Different Testing Scenarios in Reducing Transfusion-Transmitted Hepatitis B Virus (TT-HBV) Infection Risk (2022)Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum (2022)Nucleic acid testing identifies high prevalence of blood borne viruses among approved blood donors in Mozambique (2022)What is the evidence for the change in the blood donation deferral period for high-risk groups and does it go far enough? (2018)Risks and challenges of HIV infection transmitted via blood transfusion (2019)
this work references cited by second hop

References

  • 2010Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms131 cited
  • 2015Seroprevalence of infectious markers & their trends in blood donors in a hospital based blood bank in north India57 cited
  • 2013Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India56 cited
  • 2012Need for Nucleic Acid Testing in Countries with High Prevalence of Transfusion-Transmitted Infections48 cited
  • 2013Individual donor nucleic acid testing for blood safety against HIV-1 and hepatitis B and C viruses in a tertiary care hospital.48 cited
  • 2017Nucleic acid amplification testing in Indian blood banks: A review with perspectives39 cited
  • 2017Sensitivity and specificity of a new automated system for the detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus nucleic acid in blood and plasma donations39 cited
  • 2015Automated nucleic acid amplification testing in blood banks: An additional layer of blood safety36 cited
  • 2015Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety35 cited
  • 2013Evaluation of serological transfusion-transmitted viral diseases and mutliplex nucleic acid testing in malaysian blood donors18 cited
  • 2017A study of centralized individual donor nucleic acid testing for transfusion transmitted infections to improve blood safety in Karnataka, India11 cited
  • 2019Initial trends of individual donation nucleic acid testing in voluntary & replacement donors from a tertiary care centre in north India

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

7 cited
  • 2019Efficacy of Nucleic Acid Amplification Test (NAT) over Enzyme Linked Immuno Sorbent Assay (ELISA) in Detecting Transfusion Transmissible Infections (TTI) among Blood Donors at a Tertiary Care Centre5 cited
  • 2016Significance of nucleic acid testing in window period donations: Revisiting transfusion safety in high prevalence-low resource settings5 cited
  • Cited by

    No citing works inside the corpus for this window.